Orthopediatrics (NASDAQ:KIDS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Tuesday.

According to Zacks, “OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK. “

Several other equities analysts have also issued reports on KIDS. Piper Jaffray Companies assumed coverage on Orthopediatrics in a research note on Monday, November 6th. They set an “overweight” rating and a $24.00 price target on the stock. BTIG Research assumed coverage on Orthopediatrics in a research note on Monday, November 6th. They issued a “buy” rating and a $24.00 price objective on the stock. Stifel Nicolaus assumed coverage on Orthopediatrics in a research note on Monday, November 6th. They issued a “buy” rating and a $23.00 price objective on the stock. Finally, William Blair assumed coverage on Orthopediatrics in a research note on Monday, November 6th. They issued an “outperform” rating on the stock. One analyst has rated the stock with a sell rating and four have given a buy rating to the company. Orthopediatrics has a consensus rating of “Buy” and an average target price of $23.67.

Orthopediatrics (NASDAQ KIDS) opened at $19.53 on Tuesday. Orthopediatrics has a 12 month low of $17.03 and a 12 month high of $23.00. The company has a debt-to-equity ratio of -0.38, a current ratio of 2.78 and a quick ratio of 1.00.

In related news, Director Harold Ruf acquired 11,500 shares of the stock in a transaction dated Monday, October 16th. The shares were bought at an average cost of $13.00 per share, for a total transaction of $149,500.00. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.

TRADEMARK VIOLATION NOTICE: “Orthopediatrics (KIDS) Cut to Sell at Zacks Investment Research” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.watchlistnews.com/orthopediatrics-kids-cut-to-sell-at-zacks-investment-research/1799289.html.

About Orthopediatrics

OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Get a free copy of the Zacks research report on Orthopediatrics (KIDS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with Analyst Ratings Network's FREE daily email newsletter.